Linda Moors, PA-C outlines which patients with early-stage, HR+ breast cancer are eligible for Breast Cancer Index testing.

Watch the full product theater from JADPRO Live 2023: [ Ссылка ]

For intended use and limitations, visit breastcancerindex.com. Linda Moors is a consultant for Biotheranostics, Inc. Statements reflect the speaker’s own personal views and interpretation.

свернуть